Skip to main content


Fig. 3 | Cost Effectiveness and Resource Allocation

Fig. 3

From: Comparative cost-effectiveness of surgery, angioplasty, or medical therapy in patients with multivessel coronary artery disease: MASS II trial

Fig. 3

Cost-effectiveness plane in the whole study sample using 5000 replications in bootstrap. Percentages give frequencies of samples in each quadrant. The red circle represents the estimated mean values of our sample. First line (dashed line) represents 0.5 GDP per capita, $4381; second line (medium dashed line) represents 3GDP per capita, $26,288. PCI versus MT (I), PCI versus CABG (II), and CABG versus MT (III). CABG coronary artery bypass graft, PCI percutaneous coronary intervention, QALY quality-adjusted life-year, $ American dollar, GDP gross domestic product

Back to article page